Skip to main content
NIPPON CHEMIPHAR CO., LTD. logo

NIPPON CHEMIPHAR CO., LTD. — Investor Relations & Filings

Ticker · 4539 ISIN · JP3701600003 T Manufacturing
Open in API
Filings indexed 61 across all filing types
Latest filing 2026-05-21 Notice of Dividend Amou…
Country JP Japan
Listing T 4539

About NIPPON CHEMIPHAR CO., LTD.

https://www.chemiphar.co.jp/english/

NIPPON CHEMIPHAR CO., LTD. is a healthcare company engaged in the research, development, manufacture, and sale of ethical pharmaceuticals, diagnostic agents, and health-related products. The company's business focuses on three core areas: a quality-driven generic drug business, the development of innovative products based on core technologies in the field of allergy, and the creation of new drugs from proprietary technologies, including alkalization therapy. Its product portfolio addresses therapeutic areas such as lifestyle-related and allergic diseases. In the diagnostics sector, the company provides clinical testing kits and agents to support disease management and prevention.

Recent filings

Filing Released Lang Actions
剰余金の配当に関するお知らせ
Notice of Dividend Amount Classification · 87% confidence The document is a formal company announcement titled “剰余金の配当に関するお知らせ” (“Notice regarding distribution of surplus funds”), specifying record date, per-share dividend amount, total dividend amount, payment date, and rationale. This matches the “Notice of Dividend Amount” category (DIV).
2026-05-21 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan, specifically confirming the accuracy of the contents of a semi-annual report (Hankishokokusho). Since it is a regulatory filing confirming the validity of financial reporting and does not fit into the specific categories of financial reports themselves, it falls under the general regulatory filings category.
2025-11-13 Japanese
半期報告書－第94期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (半期報告書) filed by Nippon Chemiphar Co., Ltd. with the Kanto Local Finance Bureau. It contains detailed financial statements, including the balance sheet, for the interim period ending September 30, 2025. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-13 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau. Section 1 explicitly states the reason for filing is that resolutions were passed at the Annual General Meeting (AGM) held on June 19, 2025, pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act. Section 2 details the resolutions, including dividend approval, director elections, and changes to the anti-takeover defense policy, all typical outcomes of an AGM. The content focuses on the results of shareholder voting and the decisions made at the meeting. This strongly indicates a report detailing the results of a general meeting, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA) category, as it provides the official results of the shareholder vote.
2025-06-20 Japanese
内部統制報告書－第93期(2024/04/01－2025/03/31)
Governance Information Classification · 100% confidence The document header explicitly states the filing type as "内部統制報告書" (Internal Control Report) and cites the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項). Section 1 discusses the framework for internal controls over financial reporting, and Section 3 concludes that the internal controls are effective as of the end of the fiscal year (March 31, 2025). This content aligns perfectly with the requirements for an Audit Report / Information filing, which often includes internal control assessments, although it is not the full 10-K. Given the specific focus on internal control assessment and reporting structure, it fits best under the 'Audit Report / Information' category (AR), as it is a formal report on controls, distinct from a general earnings release (ER) or a full annual report (10-K).
2025-06-20 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is extremely short (559 characters) and contains a header section indicating it is a '確認書' (Confirmation Document) submitted to the Kanto Local Finance Bureau Director, referencing Article 24-2, Paragraph 1 of the Financial Instruments and Exchange Act. The main body explicitly states that the Representative Director confirmed the appropriateness of the contents of the company's '有価証券報告書' (Annual Securities Report) for the 93rd fiscal period (ending March 31, 2025). This document is a formal confirmation/attestation regarding the accuracy of a primary filing (the Annual Securities Report, which corresponds to the 10-K filing in the US context, but this specific document is the confirmation itself, not the full report). Given the definitions, this document is a specific regulatory confirmation related to the annual filing process. It is not the full 10-K, nor is it a general Audit Report (AR). It is a specific regulatory confirmation document. Since there is no specific code for a 'Confirmation of Annual Report Accuracy,' and it is a formal regulatory submission, it falls best under the general 'Regulatory Filings' (RNS) category, as it is a required submission related to compliance, or potentially related to the Audit Report/Information (AR) if interpreted as part of the assurance process, but RNS is the safest fallback for specific, non-core report submissions. However, upon re-evaluating the context: This document is a formal statement confirming the accuracy of the *Annual Securities Report* (which is the Japanese equivalent of the 10-K). In many regulatory frameworks, the certification/attestation accompanying the main report is often grouped with the report itself or treated as a specific compliance document. Since the definitions provided do not perfectly map to a Japanese 'Yukashoken Hokokusho Confirmation Document,' and it is a formal regulatory submission, RNS is the most appropriate general regulatory category. The document is not an announcement of a report (RPA), but the confirmation itself. FY 2025
2025-06-20 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.